Lonafarnib for chronic hepatitis delta: Clinical mechanism of action, development, and evolving role in combination therapy

Rakahn Haddadin; Danny Aboujamra; Jeffrey S. Glenn; Leen Kawas; Robert Taylor; Xue Hua; Tarik Asselah; Robert G. Gish

doi:10.1016/j.antiviral.2026.106442

Lonafarnib for chronic hepatitis delta: Clinical mechanism of action, development, and evolving role in combination therapy

Rakahn Haddadin
, Danny Aboujamra
, Jeffrey S. Glenn
, Leen Kawas
, Robert Taylor
, Xue Hua
, Tarik Asselah
, Robert G. Gish

Research output: Contribution to journal › Article › peer-review

Original language	English
Article number	106442
Journal	Antiviral Research
Volume	252
DOIs	https://doi.org/10.1016/j.antiviral.2026.106442
State	Published - Aug 2026
Externally published	Yes

ASJC Scopus Subject Areas

Pharmacology
Virology

Access to Document

10.1016/j.antiviral.2026.106442

OpenUrl availability

Full text

Cite this

@article{3f90a59638c240c1808f871d4a4ca73a,

title = "Lonafarnib for chronic hepatitis delta: Clinical mechanism of action, development, and evolving role in combination therapy",

author = "Rakahn Haddadin and Danny Aboujamra and Glenn, \{Jeffrey S.\} and Leen Kawas and Robert Taylor and Xue Hua and Tarik Asselah and Gish, \{Robert G.\}",

year = "2026",

month = aug,

doi = "10.1016/j.antiviral.2026.106442",

language = "English",

volume = "252",

journal = "Antiviral Research",

issn = "0166-3542",

}

TY - JOUR

T1 - Lonafarnib for chronic hepatitis delta

T2 - Clinical mechanism of action, development, and evolving role in combination therapy

AU - Haddadin, Rakahn

AU - Aboujamra, Danny

AU - Glenn, Jeffrey S.

AU - Kawas, Leen

AU - Taylor, Robert

AU - Hua, Xue

AU - Asselah, Tarik

AU - Gish, Robert G.

PY - 2026/8

Y1 - 2026/8

UR - https://www.scopus.com/pages/publications/105043901438

UR - https://www.scopus.com/pages/publications/105043901438#tab=citedBy

U2 - 10.1016/j.antiviral.2026.106442

DO - 10.1016/j.antiviral.2026.106442

M3 - Article

C2 - 42242630

AN - SCOPUS:105043901438

SN - 0166-3542

VL - 252

JO - Antiviral Research

JF - Antiviral Research

M1 - 106442

ER -

Lonafarnib for chronic hepatitis delta: Clinical mechanism of action, development, and evolving role in combination therapy

ASJC Scopus Subject Areas

Access to Document

OpenUrl availability

Other files and links

Cite this